MGC018 is an investigational antibody-drug conjugate (ADC) comprising vobramitamab, a humanized anti-B7-H3 monoclonal antibody, conjugated to the cytotoxic prodrug seco-DUBA via a cleavable linker. This ADC is designed for targeted cancer therapy research, with studies demonstrating its antitumor activity in both in vitro and in vivo models against B7-H3-expressing malignancies.
Concentration:
7.21 mg/mL
Molecular Weight:
144.64 kDa
Purity:
97.10% (May vary between batches)
CAS Number:
[2490556-50-6]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted
